{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04913",
    "Peptide Name": "S-thanatin (Ts, T15S thanatin analog, synthetic AMPs, 1S=S, UCSS1a; BBS)",
    "Source": "amino acid SUBSTITUTION, insects, animal-derived, natural derivatives",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GSKKPVPIIYCNRRSGKCQRM",
    "Sequence Length": 21,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "bacteria-agglutinating AMPs"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 2.85,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "29%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (95.24%) tothanatinK=R: 14%, I=L=G=P: 10%.Activity: active against E. coli E79466 or ATCC 25922 and 7 more resistant strains (MIC 4-12.5 ug/ml), K. pneumoniae ATCC 700603 or 7 resistant clinical strains (MIC 4-8 ug/ml), A.baumannii ATCC 19606 or 8 clincial strains (MIC>128 ug/ml), S.maltophilia ATCC 13637 or 5 resistant strains (MIC >128 ug/ml), P.aeruginosa ATCC 15442 or 7 resistant clincial strains (MIC>128 ug/ml), E. cloacae ATCC 13047 or 6 clinical strains (MIC 8-16 ug/ml), S.marcescens ATCC 14041 or 5 clincial strains (MIC > 128 ug/ml), E. aerogenes ATCC 49701 or 7 clinical strains (MIC 4 ug/ml), P.mirabilis ATCC 12453 or 6 clinical strains (MIC >128 ug/ml), K. ornithinolytica ATCC 31898 or 4 clinical strains (MIC 8 ug/ml), K. oxytoca ATCC 43086 or 4 clincial strains (MIC 8 ug/ml), S.aureus ATCC 12228 or 7 clinical strains (MIC > 128 ug/ml), S.hominis ATCC 29970 or 9 clinical strains (MIC >128 ug/ml), E. faecium ATCC 29212 or 5 clinical strains (MIC 64-128 ug/ml) 1 strain 128 ug/ml, S.agalactiae (MIC>128 ug/ml), and B.subtilis (MIC 104 uM) (Wu et al., 2011). It also binds LPS and can agglutinates bacteria (bacteria-agglutinating).In vivo toxicity: LD50=458 mg/kg (IV). The peptide appears to be safe when IV injected up to 125 mg/kg (Wu et al., 2012).Animal model:mouse:  in combination with ceftazidime, the peptide showed dose-dependent protection (10-40 mg/kg) of animals from death.",
    "Author": "Wu G, Fan X, Li L, Wang H, Ding J, Hongbin W, Zhao R, Gou L, Shen Z, Xi T. 2010",
    "Reference": "Int J Antimicrob Agents. 2010 Mar;35(3):250-4. doi: 10.1016/j.ijantimicag.2009.11.009.PubMed",
    "Title": "Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli."
  },
  "3D Structure": []
}